Wells Fargo sees ‘room to run’ for Johnson & Johnson, highlights pharma upside
PositiveFinancial Markets

Wells Fargo has expressed optimism about Johnson & Johnson, suggesting that there is significant potential for growth in the pharmaceutical sector. This is important as it highlights the confidence in J&J's future performance, particularly in its drug development pipeline, which could lead to increased investments and a positive impact on the market.
— Curated by the World Pulse Now AI Editorial System